MODELING CARDIOVASCULAR OUTCOMES OF TREATMENT WITH EMPAGLIFLOZIN IN TYPE 2 DIABETES BASED ON HARD OUTCOMES DATA
Abstract
Authors
A. Kansal Y. Zheng I. Proskorovsky S. Krotneva P. Kandaswamy A. Ruffolo
A. Kansal Y. Zheng I. Proskorovsky S. Krotneva P. Kandaswamy A. Ruffolo
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now